Pretrial Rulings Affirmed In N.J.'s First Aredia/Zometa Trial

Pretrial Rulings Affirmed In N.J.'s First Aredia/Zometa Trial

TRENTON, N.J. - A New Jersey appeals panel yesterday affirmed several pretrial rulings in the state's first Aredia/Zometa jaw injury trial, including one that direct-to-consumer advertising by defendant Novartis Pharmaceuticals Corp. did not trigger ...read more